Alphatec Holdings (ATEC) Net Income towards Common Stockholders (2010 - 2026)

Alphatec Holdings (ATEC) reported Net Income towards Common Stockholders of -$33.9 million for Q1 2026, up 34.68% on a YoY basis from -$25.2 million in Q1 2025, and down 56.04% sequentially from -$21.7 million in Q4 2025.

Alphatec Holdings (ATEC) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Alphatec Holdings (ATEC) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$33.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 34.68% year-over-year to -$33.9 million; the trailing twelve-month figure through Mar 2026 stood at -$125.4 million (up 24.27% YoY), and the FY2025 full-year result was -$143.4 million, up 11.57% from the prior year.
  • Net Income towards Common Stockholders eased to -$33.9 million in Q1 2026, from -$21.7 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$21.7 million in Q4 2025 to a low of -$51.9 million in Q1 2025.
  • A 5-year average of -$39.8 million and a median of -$40.7 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • Across the five-year window, Net Income towards Common Stockholders tumbled 86.07% in 2022 and jumped 34.81% in 2025, its largest moves.
  • Tracing ATEC's Net Income towards Common Stockholders over 5 years: stood at -$34.8 million in 2022, then plunged by 41.1% to -$49.1 million in 2023, then jumped by 32.08% to -$33.3 million in 2024, then jumped by 34.81% to -$21.7 million in 2025, then slumped by 56.04% to -$33.9 million in 2026.
  • Business Quant data shows ATEC's Net Income towards Common Stockholders at -$33.9 million in Q1 2026, -$21.7 million in Q4 2025, and -$28.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 183.01 Bn 175.72 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.76 Bn 125.88 Bn 3.81 Bn 745.00 Mn
3 Medtronic 108.90 Bn 99.68 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 68.43 Bn 66.98 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 47.96 Bn 44.29 Bn 1.29 Bn -
6 GE HealthCare Technologies 28.29 Bn 26.01 Bn 1.98 Bn 411.00 Mn
7 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 199.50 Mn
8 Smith & Nephew 26.89 Bn 26.31 Bn - -
9 Koninklijke Philips 25.44 Bn 22.31 Bn 2.07 Bn 176.78 Mn
10 Alphatec Holdings 1.35 Bn 1.21 Bn 136.48 Mn -33.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -33.91 Mn
Dec 31, 2025 -21.73 Mn
Sep 30, 2025 -28.58 Mn
Jun 30, 2025 -41.14 Mn
Mar 31, 2025 -51.91 Mn
Dec 31, 2024 -33.33 Mn
Sep 30, 2024 -39.62 Mn
Jun 30, 2024 -40.68 Mn
Mar 31, 2024 -48.50 Mn
Dec 31, 2023 -49.08 Mn
Sep 30, 2023 -42.65 Mn
Jun 30, 2023 -51.38 Mn
Mar 31, 2023 -43.53 Mn
Dec 31, 2022 -34.78 Mn
Sep 30, 2022 -36.79 Mn
Jun 30, 2022 -37.10 Mn
Mar 31, 2022 -42.62 Mn
Dec 31, 2021 -38.89 Mn
Sep 30, 2021 -43.03 Mn
Jun 30, 2021 -38.21 Mn